头颈部肿瘤进口抗癌药——西妥昔单抗(cetuximab)不良反映

印度代购提示您，本品不良反应：

最常见不良反应(发生率≥25%)是：皮肤不良反应(包括皮疹，瘙痒，和指甲变化)，头痛，腹泻，和感染。

The most common adverse reactions (incidence ≥25%) were: skin adverse reactions (including rash, itching, and nail changes), headache, diarrhea, and infection.

印度代购提示您，本品特殊人群中的使用妊娠：

只有潜在效益合理大于对胎儿潜在风险时才给妊娠妇女Erbitux。哺乳母亲：用Erbitux治疗期间和后60天终止哺乳。

Erbitux should be given to pregnant women only if the potential benefits reasonably outweigh the potential risks to the fetus. For nursing mothers: Stop breastfeeding during and after 60 days of treatment with Erbitux.